Inherited cardiac conditions Flashcards
Jerky pulse
Forceful or double apical impulse
4th heart sound
Mid systole murmur exaggerated by Valsalva manoeuvre (30-40% patients)
Hypertrophic cardiomyopathy
Pathological effect:
- LVOT obstruction
- Mitral regurgitation
Rapid x and y descent of the JVP
Loud 3rd and 4th heart sound
Restrictive cardiomopathy
myocardial cell hypertrophy increased length without increased diameter
large bizarrely shaped nuclei
myocyte atrophy and myofilament loss
increased interstitial fibrosis
Dilated cardiomyopathy
Increased systolic and diastolic volume with low Ejection Fraction
Incidence increases with age and men are more commonly affected
It may be idiopathic, familial/genetic, viral, autoimmune or immune-mediated associated with a viral infection.
Dilated cardiomyopathy
Heart muscle is replaced by fibrous and fatty tissue.
Predominately affects the right ventricle.
Arrhythmogenic right ventricular cardiomyopathy
T-wave inversion beyond lead V1. Evidence of right ventricular electrical disturbance is manifest by a QRS duration in V1 > or = 110 msec and a longer QRS duration in the right then left precordial leads.
Evidence of slow fractionated conduction is present as epsilon waves. The signal averaged ECG may show exceedingly long and low late potentials.
ARVC
Genetics of HCM?
Autosomal dominant
Epsilon waves
ARVC
Definition of familial DCM?
The definition of familial dilated cardiomyopathy (DCM) is clinically based on the presence, in the same family, of at least two members proven as affected.
Familial DCM is commonly inherited as autosomal dominant trait; less frequently it is autosomal recessive, X-linked.
Genetics of AVRC
In most families, dominant with variable penetrance
What defines QT prolongation?
QTc >440ms in males , >460ms in females
Brugada syndrome
Cardiac sodium channel mutation
Risk of polymorphic VT, VF
Atrial fibrillation common
ST elevation and RBBB in V1-V3
ECG findings may be intermittent, change over time
Diagnostic ECG changes may seen only with provocative testing with flecainide or ajmaline (drugs that block the cardiac sodium channel)
ST elevation and RBBB in V1-V3
Brugada syndrome
How would you establish ECG changes of Brugada syndrome?
Diagnostic ECG changes may seen only with provocative testing with flecainide or ajmaline (drugs that block the cardiac sodium channel)